Histochemical and immunohistochemical study of diffuse large-cell lymphomas

Area of Science:

• Hematology
• Oncology
• Immunohistochemistry

Background:

• Diffuse large-cell lymphoma (DLCL), also known as diffuse histiocytic lymphoma, is a heterogeneous group of non-Hodgkin lymphomas.
• Accurate subclassification is crucial for understanding disease biology and guiding treatment strategies.

Purpose of the Study:

• To subclassify ninety cases of diffuse large-cell lymphoma into distinct subtypes.
• To characterize the enzyme histochemical and immunohistochemical features of each subtype.
• To correlate subtypes with clinical behavior and treatment response.

Main Methods:

• Enzyme histochemistry and immunohistochemistry were employed to analyze cellular characteristics.
• Ninety DLCL cases were assessed for specific enzyme activities (acid phosphatase, non-specific esterases) and markers (monoclonal immunoglobulin, lysozyme).
• Subtypes were identified based on characteristic enzyme profiles and cellular morphology.

Main Results:

• Ninety diffuse large-cell lymphomas were classified into B-cell (74 cases), T-cell, and histiocytic types.
• B-cell lymphomas showed intracellular monoclonal immunoglobulin; T-cell lymphomas had focal acid phosphatase activity and convoluted nuclei; histiocytic lymphomas exhibited esterase activity, lysozyme, and phagocytosis.
• B-cell lymphomas were further divided into follicular center cell type and B-cell immunoblastic sarcoma.
• Preliminary data indicated histiocytic type lymphoma is most treatment-resistant.
• B-cell immunoblastic sarcomas demonstrated greater aggressiveness than follicular center cell neoplasms.

Conclusions:

• Enzyme histochemistry and immunohistochemistry effectively subclassify diffuse large-cell lymphomas.
• The B-cell type is the most prevalent subtype.
• Distinct subtypes exhibit varying clinical aggressiveness and treatment responses, with histiocytic type being the least responsive.